How Valeant Cashed In Twice on Higher Drug Prices
vendredi 29 juillet 2016
By GRETCHEN MORGENSON from NYT Business Day http://ift.tt/2aQ2psi
via IFTTTIt wasn’t just soaring drug prices that helped Valeant Pharmaceuticals’ cash flow. A credit for inventories at those higher prices also plumped the figures. July 31, 2016 at 05:00AM
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire